<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2025-09-02)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2025-09-02)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>StockWatch: Analysts See $10B+ in Sales for Lilly Oral GLP-1</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-09-02</em></p>
<p>In the primary endpoint of mean percent change in body weight from average baseline of 223.5 lbs, orforglipron 36 mg, taken once daily without food and water restrictions, lowered weight by an average of 10.5% (22.9 lbs) vs. 2.2% (5.1 lbs) with placebo. The 36 mg dosage also produced A1C reductio...</p>
<p><a href='https://www.genengnews.com/gen-edge/stockwatch-analysts-see-10b-in-sales-for-lilly-oral-glp-1/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Nvidia-backed Charm Therapeutics gets $80M to take AI-designed cancer drug to clinic</h3>
<p class='source-date'><em>Endpoints News • 2025-09-02</em></p>
<p>A biotech co-founded by Nobel laureate David Baker has reeled in an $80 million Series B to get into the clinic early next year with an AI-designed cancer drug. The London-based startup ...</p>
<p><a href='https://endpoints.news/nvidia-backed-charm-therapeutics-gets-80m-to-take-ai-designed-cancer-drug-to-clinic/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Blood Cancer Awareness Month: What biotech holds in store</h3>
<p class='source-date'><em>Labiotech.eu • 2025-09-01</em></p>
<p>As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines. The post Blood Cancer Awareness Month: What biotech holds in store appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of...</p>
<p><a href='https://www.labiotech.eu/in-depth/blood-cancer-awarness-month/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>#ESC25: Novartis' Leqvio cuts lipid levels, muscle pain in high-risk cholesterol patients</h3>
<p class='source-date'><em>Endpoints News • 2025-08-30</em></p>
<p>MADRID — Novartis’ cholesterol-cutting medicine Leqvio swiftly improved high-risk patients’ lipid levels when added to standard of care, according to data presented Saturday at the annual meeting of the European Society of Cardiology. The Phase 4 ...</p>
<p><a href='https://endpoints.news/esc25-novartis-leqvio-cuts-lipid-levels-muscle-pain-in-high-risk-cholesterol-patients/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>#ESC25: Ionis' study success in moderately high triglyceride levels raises the curtain for pivotal readout in severe disease</h3>
<p class='source-date'><em>Endpoints News • 2025-08-30</em></p>
<p>MADRID — Ionis Pharmaceuticals’ Tryngolza reduced triglycerides in patients with moderately high levels of these fat molecules in a late-stage test, according to data presented Saturday at the annual meeting of the European Society of Cardiology ...</p>
<p><a href='https://endpoints.news/esc25-ionis-study-success-in-moderately-high-triglyceride-levels-raises-the-curtain-for-pivotal-readout-in-severe-disease/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>#ESC25: Alnylam to kick off CV events trial of zilebesiran despite mid-stage blood pressure miss</h3>
<p class='source-date'><em>Endpoints News • 2025-08-30</em></p>
<p>MADRID — Alnylam Pharmaceuticals said it will start a Phase 3 cardiovascular outcomes trial of its hypertension therapy zilebesiran this year, despite data showing the drug failed in a mid-stage study. Called KARDIA-3, the Phase 2 ...</p>
<p><a href='https://endpoints.news/esc25-alnylam-to-kick-off-cv-events-trial-of-zilbesiran-despite-mid-stage-blood-pressure-miss/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<p>No recent microbiome news available today.</p>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<div class='paper-item'>
<h4>Correction: Microbial exchange at the wildlife-livestock interface: insights into microbial composition, antimicrobial resistance and virulence factor gene dynamics in grassland ecosystems.</h4>
<p class='source-date'><em>Kauer Lea, Sapountzis Panagiotis, Imholt Christian et al. | Animal microbiome • 2025-09-01</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1186/s42523-025-00458-0' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>DeepSEA: an alignment-free explainable approach to annotate antimicrobial resistance proteins.</h4>
<p class='source-date'><em>Borelli Tiago Cabral, Paschoal Alexandre Rossi, da Silva Ricardo Roberto | BMC bioinformatics • 2025-09-01</em></p>
<p><strong>Abstract:</strong> Antimicrobial resistance (AMR) is one of the most concerning modern threats as it places a greater burden on health systems than HIV and malaria combined. Current surveillance strategies for tracking antimicrobial resistance (AMR) rely on genomic comparisons and depend on sequence alignment with ...</p>
<p><a href='https://doi.org/10.1186/s12859-025-06256-4' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Colistin resistance in the era of antimicrobial resistance: challenges and strategic countermeasures.</h4>
<p class='source-date'><em>RoyChowdhury Debasrita, Manna Arnima, Mandal Sukhendu et al. | Folia microbiologica • 2025-09-01</em></p>
<p><strong>Abstract:</strong> Colistin resistance represents a mounting global health concern, particularly alarming in the face of multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacterial infections. As a polymyxin-class antibiotic, colistin has long served as a critical last-line defence against severe Gram-...</p>
<p><a href='https://doi.org/10.1007/s12223-025-01322-z' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Global trends of antimicrobial resistance and virulence of Klebsiella pneumoniae from different host sources.</h4>
<p class='source-date'><em>Huang Xi, Yao Xinzhi, Hou Yanyan et al. | Communications medicine • 2025-09-01</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Klebsiella pneumoniae is ubiquitous in animals, humans, and the environment, facilitating the dissemination of antimicrobial resistance (AMR) and virulence traits. Most studies are primarily focused on human clinical isolates, leaving critical gaps in understanding non-human reservoir...</p>
<p><a href='https://doi.org/10.1038/s43856-025-01112-1' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Mitigating antimicrobial resistance by innovative solutions in AI (MARISA): a modified James Lind Alliance analysis.</h4>
<p class='source-date'><em>Waldock William J, Thould Hannah, Chindelevitch Leonid et al. | npj antimicrobials and resistance • 2025-09-01</em></p>
<p><strong>Abstract:</strong> Antimicrobial resistance (AMR) is a critical global health threat and artificial intelligence (AI) presents new opportunities for our response. However, research priorities at the AI-AMR intersection remain undefined. This study aimed to identify and prioritise key areas for future investigation....</p>
<p><a href='https://doi.org/10.1038/s44259-025-00150-y' target='_blank'>View Paper</a></p>
</div>
<h3>Synthetic & Molecular Biology Papers</h3>
<div class='paper-item'>
<h4>Identification of severity related mutation hotspots in SARS-CoV-2 using a density-based clustering approach.</h4>
<p class='source-date'><em>Youn Sohyun, Jeong Dabin, Kwon Hwijun et al. | BioData mining • 2025-09-01</em></p>
<p><strong>Abstract:</strong> BACKGROUND: The immune response to SARS-CoV-2 varies greatly among individuals yielding highly varying severity levels among the patients. While there are various methods to spot severity associated biomarkers in COVID-19 patients, we investigated highly mutated regions, or mutation hotspots, wit...</p>
<p><a href='https://doi.org/10.1186/s13040-025-00476-3' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Sodium tanshinone IIA sulfonate alleviates osteoarthritis through targeting SIRT1.</h4>
<p class='source-date'><em>Xu Mao, Sun Xulei, Ma Xiao et al. | Chinese medicine • 2025-09-01</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Osteoarthritis (OA), a chronic degenerative disease, is characterized by the loss of articular cartilage, impacting more than 500 million individuals worldwide. Sodium tanshinone IIA sulfonate (STS) is a water-soluble derivative of tanshinone IIA derived from Salvia miltiorrhiza and h...</p>
<p><a href='https://doi.org/10.1186/s13020-025-01166-2' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3.</h4>
<p class='source-date'><em>Liu Chang, Wang Xin, Xu Chao et al. | BMC neurology • 2025-09-01</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Hereditary ataxias (HAs) are neurodegenerative disorders characterized by progressive cerebellar degeneration, with autosomal dominant spinocerebellar ataxias (SCAs) representing the most prevalent subtype. SCA3, the most common form worldwide, is caused by CAG repeat expansions in AT...</p>
<p><a href='https://doi.org/10.1186/s12883-025-04378-z' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Behind the scenes of Popillia japonica integrated pest management: differentially expressed gene analysis following different control treatments.</h4>
<p class='source-date'><em>Cucini Claudio, Funari Rebecca, Marturano Giovanni et al. | BMC genomics • 2025-09-01</em></p>
<p><strong>Abstract:</strong> BACKGROUND: The Japanese beetle Popillia japonica is an invasive pest that is creating a major concern due to its spread and damaging potential. Native to Japan, it was introduced in the U.S.A. and the Azores during the twentieth century, and in mainland Europe in 2014. P. japonica is able to att...</p>
<p><a href='https://doi.org/10.1186/s12864-025-11949-4' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Spatialsmooth: a spatially-aware convolutional autoencoder framework for enhanced deconvolution of spatial transcriptomics data.</h4>
<p class='source-date'><em>Yang Xiao, Xiang Jinjin, Feng Yanbin et al. | BMC genomics • 2025-09-01</em></p>
<p><strong>Abstract:</strong> Spatial transcriptomics technologies have revolutionized our understanding of tissue heterogeneity by providing gene expression data with spatial context. However, due to the limited resolution of some of these techniques, multiple cell types are often captured at each spatial location. Several s...</p>
<p><a href='https://doi.org/10.1186/s12864-025-11959-2' target='_blank'>View Paper</a></p>
</div>
<h3>Bacteriophage Research Papers</h3>
<div class='paper-item'>
<h4>Colistin resistance in the era of antimicrobial resistance: challenges and strategic countermeasures.</h4>
<p class='source-date'><em>RoyChowdhury Debasrita, Manna Arnima, Mandal Sukhendu et al. | Folia microbiologica • 2025-09-01</em></p>
<p><strong>Abstract:</strong> Colistin resistance represents a mounting global health concern, particularly alarming in the face of multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacterial infections. As a polymyxin-class antibiotic, colistin has long served as a critical last-line defence against severe Gram-...</p>
<p><a href='https://doi.org/10.1007/s12223-025-01322-z' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Characterization and therapeutic evaluation of the lytic bacteriophage ENP2309 against vancomycin-resistant Enterococcus faecalis infections in a mice model.</h4>
<p class='source-date'><em>Tian Jiaqi, Wang Luyao, Gao Rui et al. | Virology journal • 2025-08-28</em></p>
<p><strong>Abstract:</strong> BACKGROUND: The global emergence of vancomycin-resistant Enterococci (VRE) represents a growing threat to public health worldwide. To address this critical challenge, we isolated and characterized a novel lytic bacteriophage, ENP2309, from agricultural wastewater. Comprehensive analysis revealed ...</p>
<p><a href='https://doi.org/10.1186/s12985-025-02917-1' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Emergence of the zoonotic bacterium Necropsobacter rosorum in nutria Myocastor coypus with implications for wildlife and human health.</h4>
<p class='source-date'><em>Laidoudi Younes, Davoust Bernard, Lepidi Hubert et al. | Scientific reports • 2025-09-01</em></p>
<p><strong>Abstract:</strong> The nutria (Myocastor coypus), a semi-aquatic rodent native to South America, poses significant ecological and agricultural threats as an invasive species in France, where it continues to proliferate despite sustained control efforts. A fatal case of pneumonia in a nutria from Marseille (France) ...</p>
<p><a href='https://doi.org/10.1038/s41598-025-15792-1' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Nanofilament immunotherapy induces potent antitumor vaccine responses.</h4>
<p class='source-date'><em>Neil Kevin, Génier Samuel, Poisson Marie-Ève et al. | Journal for immunotherapy of cancer • 2025-08-31</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Checkpoint inhibitors revolutionized cancer treatment by potentiating antitumor immune responses. However, many patients do not respond to these therapies, often due to the lack of a pre-existing immune response against cancer cells. Developing immunotherapies that promote cancer-cell...</p>
<p><a href='https://doi.org/10.1136/jitc-2024-011331' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Development of autoimmune antibodies against human phospholipase A2 receptor and the application as diagnostic criteria for primary membranous nephropathy.</h4>
<p class='source-date'><em>Wu Shukun, Zhai Yixing, Yang Na et al. | Clinical nephrology • 2025-09-01</em></p>
<p><strong>Abstract:</strong> INTRODUCTION: Membranous nephropathy (MN) is a severe chronic kidney disease (CKD) with ~ 30% of patients progressing to end-stage renal disease within 10 years. Phospholipase A2 receptor (PLA2R) is one of the major target antigens of MN. Despite the importance of PLA2R antibodies in the pathogen...</p>
<p><a href='https://doi.org/10.5414/CN111747' target='_blank'>View Paper</a></p>
</div>
<h3>Skin Microbiome & Disease Papers</h3>
<div class='paper-item'>
<h4>Inflammatory biomarkers predict Cutibacterium acnes detection at the portal area during arthroscopic shoulder surgery.</h4>
<p class='source-date'><em>Uehara Kazuya, Yukata Kiminori, Imagama Takashi et al. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association • 2025-08-30</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Cutibacterium acnes (C. acnes), a gram-positive bacterium commonly found in the pilosebaceous glands of the shoulder, represents a significant source of infection following shoulder surgery. Identifying patients at higher risk for bacterial contamination prior to surgery could facilit...</p>
<p><a href='https://doi.org/10.1016/j.jos.2025.08.003' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Author Correction: The human skin microbiome: from metagenomes to therapeutics.</h4>
<p class='source-date'><em>Oh Julia, Voigt Anita Y | Nature reviews. Microbiology • 2025-08-29</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1038/s41579-025-01238-y' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Skin microbiome as a signature of premature ageing appearance: Manipulation through by use of topical products.</h4>
<p class='source-date'><em>Xu Yi-Ning, Pu Mingming, Raut Janhavi et al. | The British journal of dermatology • 2025-08-27</em></p>
<p><strong>Abstract:</strong> BACKGROUND/OBJECTIVES: Perceived facial age and chronological age can show strong discrepancy due to differential magnification of age-related features, such as wrinkles or hyperpigmented spots, that affects overall ageing appearance. The perceived skin age of an individual can hence vary signifi...</p>
<p><a href='https://doi.org/10.1093/bjd/ljaf098' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Elevated Kocuria rhizophila contributing to repair of skin barrier function in patients with atopic dermatitis.</h4>
<p class='source-date'><em>Park Hyunjoon, Lee Chaewon, Huh Chul Sung et al. | Allergology international : official journal of the Japanese Society of Allergology • 2025-08-29</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Recent findings suggest skin microbiota is closely linked to the aggravation of atopic dermatitis (AD) and skin barrier dysfunction. METHODS: This prospective cross-sectional study included 52 children: 35 with AD flare (F) and non-flare (NF), and 17 without AD (non-AD). Microbes in t...</p>
<p><a href='https://doi.org/10.1016/j.alit.2025.06.006' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Microneedle-mediated delivery of hydroxypropyl-β-cyclodextrin-encapsulated Angelica sinensis (Danggui) essential oil for acne treatment: efficacy and mechanisms.</h4>
<p class='source-date'><em>Liu Xiaoli, Li Xiaojuan, He Weijun et al. | Drug delivery and translational research • 2025-08-29</em></p>
<p><strong>Abstract:</strong> Acne is a multifactorial dermatological condition driven by Propionibacterium acnes (P. acnes) infection, inflammation, and sebum dysregulation. While essential oils, such as Angelica sinensis (Danggui) essential oil (AEO), exhibit antimicrobial and anti-inflammatory properties, their clinical ap...</p>
<p><a href='https://doi.org/10.1007/s13346-025-01953-2' target='_blank'>View Paper</a></p>
</div>
<hr>
<p><em>Report generated on 2025-09-02</em></p>
</div>
</body>
</html>